About you
What is your name?
Full name
(Required)
Dr. Phillip Altman
Which best describes your response? Please read the definition of "on behalf of an organisation" at the top of this page before responding.
Please select one item
(Required)
Radio button:
Ticked
I am responding as an individual
Radio button:
Unticked
I am responding on behalf of an organisation / institution
Individual
Which best describes you?
Please select one item
Radio button:
Unticked
Consumer / patient
Radio button:
Unticked
Registered healthcare professional
Radio button:
Ticked
Professional researcher
Radio button:
Unticked
None of the above / I am responding out of personal interest
Consultation Page
Please select the substance you would like to comment on:
Substance:
Please select one item
Radio button:
Ticked
Ivermectin
Radio button:
Unticked
Brimonidine
Radio button:
Unticked
Fexofenadine
Radio button:
Unticked
Ibuprofen
Radio button:
Unticked
Melatonin
Radio button:
Unticked
Green tea extract
Radio button:
Unticked
Ethalfluralin
Radio button:
Unticked
Tigolaner
Please select one item
(Required)
Radio button:
Ticked
Fully support
Radio button:
Unticked
Partially support
Radio button:
Unticked
Oppose
Written response:
I have previously submitted 2 Open Letters to the National Covid Clinical Evidence Taskforce (dated 21 August 2021 and 14 October 2021). No response whatsoever was received. The submissions were ignored. These submissions are now re-submitted in the hope they will be considered due to national importance.